CD8A and neoplasm: Mice were randomised into 4 groups, receiving an inoculation of PBS as a control, OT-I CD8+ T cells, APS-MNP-loaded OT-I CD8+ T cells, or APS-MNP-loaded OT-I CD8+ T cells together with the application of an EMF over the tumour for approximately 90 min (Fig. 7a).